Bone metastasis attenuates efficacy of immune checkpoint inhibitors and displays “cold” immune characteristics in Non-small cell lung cancer

Lung Cancer(2022)

引用 9|浏览11
暂无评分
摘要
•Bone metastasis attenuates efficacy of immune checkpoint inhibitors in NSCLC patients.•Bone metastasis negatively affects clinical outcomes irrespective of PD-L1 expression.•Bone metastatic NSCLC patients display “cold” immune characteristics.
更多
查看译文
关键词
Non-small cell lung cancer,Bone metastasis,Immune checkpoint inhibitor,Tumor immune micro-environment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要